479 Results (Page 3 of 20)
Canada Markets Research Reports
Canada Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the Canada Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.
Canada Conjunctivitis Therapeutics Market Analysis
The Canada Conjunctivitis Therapeutics Market was valued at $328 Mn in 2022 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $500 Mn by 2030. The key drivers of this industry include the increasing prevalence of conjunctivitis, increasing healthcare expenditure, and advancements in the therapeutics industry. The industry is primarily dominated by players such as Allergan, Pfizer, Novartis, Johnson & Johnson, Alcon, and Sandoz among others.
Canada Chronic Cough Therapeutics Market Analysis
Canada Chronic Cough Therapeutics Market was valued at $504 Mn in 2022 and is estimated to reach $940 Mn in 2030, exhibiting a CAGR of 8.1% during the forecast period. The primary factor propelling the chronic cough therapeutics market is the widespread occurrence of chronic respiratory infections, given that chronic cough serves as a prevalent indication for such conditions. Currently, major players in this market include GlaxoSmithKline, Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Boehringer Ingelheim, Procter & Gamble (P&G), Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc., Jamieson Laboratories, and Hyland's Homeopathic.
Canada Cold Pain Therapy Market Analysis
The Canada Cold Pain Therapy Market was valued at $176 Mn in 2022 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $264 Mn by 2030. The key drivers of this industry include the increasing prevalence of pain disorders, focus on non-pharmaceutical options, product innovation, and technological advances. The industry is primarily dominated by players such as Hisamitsu, Polar Products, Rapid Aid, Romsons, Pic Solution, and Unexo among others.
Canada Artificial Intelligence (AI) in Medical Imaging Market Analysis
Canada's Artificial Intelligence (AI) in Medical Imaging market size was valued at $120 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 35.4% from 2022 to 2030 and will reach $1356Mn. The market is segmented by AI technology, solution, modality, application, and end User. The Canada Artificial Intelligence (AI) in the Medical Imaging market will grow due to advances in AI and machine learning algorithms that are making it possible to develop more accurate and efficient medical imaging software. Some of the key players in this market are Imagia, Intelerad Medical Systems, Aifred Health, HeartForce Medical, Swift Medical, Resolution Health, Hooton AI (Vancouver, British Columbia) and others.
Canada Electronic Records Management Solutions Market Analysis
Canada's electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. Canada’s Electronic Records Management Solutions market will grow the need for better information management, rising regulatory compliance standards, and rising demand for digitalization in Canada. The key market players are OpenText (CAN), Ricoh Canada (CAN), Iron Mountain (CAN), DocuSign (CAN), and others.
Canada Artificial Intelligence (AI) in Healthcare Market Analysis
This report presents a strategic analysis of the Canada Artificial Intelligence (AI) in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Artificial Intelligence (AI) in Healthcare Market, offering unmatched value, accuracy and expert insights.
Canada Central Nervous System (CNS) Therapeutics Market Analysis
The Canada Central Nervous System (CNS)Therapeutics Market was valued at US $16.8 Bn in 2022 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to US $27.596 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of CNS diseases, supportive government initiatives, and technological factors. The industry is primarily dominated by players such as Pfizer, Novartis, Teva Pharmaceutical, Otsuka, AbbVie, Roche, and Eli Lilly among others.
Canada Clinical Diagnostics Market Analysis
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth. The market is segmented by molecular diagnostics and end users. LifeLabs, SickKids, and Dynacare are some of the top players in this market.
Canada Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the Canada Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Healthcare Reimbursement Market, offering unmatched value, accuracy, and expert insights.
Canada Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the Canada Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Patient Support Programs (PSP) Market, offering unmatched value, accuracy, and expert insights.
Canada Digital Health Market Analysis
Canada's digital market size was valued at $16.88 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 18.6% from 2022 to 2030 and will reach $66.07 Bn in 2030. The rising popularity of remote patient monitoring services will drive Canada home healthcare market expansion. The market is segmented by solution, deployment, and end user. the key market players are MEDITECH, Oracle Cerner Corporation, Epic Systems Corporation, and others.
Canada ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The Canada ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $2.365 Bn in 2022 to $3.287 Bn by 2030, registering a CAGR of 4.20% during the forecast period of 2022 - 2030. The number of individuals diagnosed with ADHD is on the rise, leading to a higher demand for ADHD medications. Some of the key players in the US ADHD drugs market include Shire (now part of Takeda), Johnson & Johnson, Novartis, Pfizer, Eli Lilly and Company, Concert Pharmaceuticals, Aevi Genomic Medicine, Neos Therapeutics, Vayarin, Supernus Pharmaceuticals.
Canada Home Healthcare Market Analysis
Canada's home healthcare market is expanding at the market size of about $29 Bn in 2022 with a CAGR of 7.93% and is forecasted to grow up to $53 Bn in the year 2030 due to the aging population and the associated increase in disease rates. The Canada home healthcare market analysis is segmented by device type, service type, and by indication type. Johnson and Johnson, Omron Healthcare, and 3M Healthcare are the major players in the home healthcare market.
Canada Telemedicine Market Analysis
The Canada Telemedicine market was valued at $4.864 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 18.2% from 2022 to 2030 and will reach $18.532 Bn in 2030. One of the main reasons propelling the growth of this market is the advent of advanced technologies, rising cases of chronic and lifestyle related disease. The market is segmented by end user, product type and Delivery mode. Some key players in this market are Cerner Corporation, GE Healthcare, Physiotherapy Ltd etc.
Canada Pharmaceutical Market Analysis
Canada's pharmaceutical market size is about $83.08 Bn in 2022 and is expected to witness significant growth of about $141.69 Bn in 2030 with a CAGR of 6.9% as there are a large number of overseas pharmaceutical companies having a presence in Canada. The incidences of chronic diseases among the Canadian population and comorbidities associated with the diseases are likely to positively impact the growth of the pharmaceutical market over the forecast period. The market is segmented by formulation type, route of administration type and prescription type, etc. Some of the leading players in the market are Pfizer, Novartis AG, and Roche.
Canada Physiotherapy Market Analysis
Canada's physiotherapy market size was valued at $4.25 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.85% from 2022 to 2030 and will reach $6.70 Bn in 2030. The Canada physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The major players in the Canada physiotherapy market are BTL Industries, Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
Canada Pain Management Devices Market Analysis
This report presents a strategic analysis of the Canada Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Pain Management Devices Market, offering unmatched value, accuracy, and expert insights.
Canada Primary Hyperoxaluria (PH) Drugs Market Analysis
Canada Primary Hyperoxaluria (PH) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Unmet Medical Need, Increasing Awareness and Diagnosis, Advancements in Research and Development, Growing Investment and Pipeline Development, Collaboration and Patient Advocacy,rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Drugs Market are Allena Pharmaceuticals, Inc., Intellia Drugs, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
Canada Castrate Resistant Prostate Cancer Therapeutics Market Analysis
Canada Castrate Resistant Prostate Cancer Therapeutics Market valued at $816 Mn in 2022, projected to reach $1413 Mn by 2030 with a 7.10% CAGR. The key drivers of growth include the persistent unmet medical need for a cure, which fuels extensive research and development efforts for innovative treatments, as well as the transformative impact of technological innovations such as precision medicine, and a shift towards patient-centric priorities focusing on improved quality of life and less intrusive treatment options. The Canada Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Bayer, Roche, Sanofi, Novartis, AstraZeneca, Apotex, Paladin Labs, Bausch etc, among various others.
Canada Alzheimer’s Therapeutics Market Analysis
Canada Alzheimer’s therapeutics market was valued at $384 Mn in 2022 and is estimated to reach $771 Mn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The rising prevalence of Alzheimer's disease and the approval of therapies that modify the illness are expected to propel the market's growth. Biogen, Eisai, Roche, Novartis, Pfizer, Eli Lilly, Johnson & Johnson, AbbVie, AstraZeneca and Lundbeck are top leading pharmaceutical companies that are presently operating in the market
Canada Infectious Disease Drugs Market Analysis
Canada Infectious Disease Drugs Market valued at $9.5 Bn in 2023, projected to reach $12.73 Bn by 2030 with a 4.27% CAGR. The market is driven by factors such as rising rates of infectious diseases, technological developments in medication development, and expanding healthcare infrastructure and awareness. The market is dominated by key players like Gilead Sciences, AbbVie Inc., GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, Pfizer Inc., and Sanofi.
Canada Atopic Dermatitis Therapeutics Market Analysis
The Canada Atopic Dermatitis Therapeutics Market was valued at US $0.984 Bn in 2022, and is predicted to grow at (CAGR) of 8.8% from 2023 to 2030, to US $1.93 Bn by 2030. The key drivers of this industry include the rising prevalence of Atopic Dermatitis (AD), expansion in healthcare coverage and supportive government initiatives. The industry is primarily dominated by players such as Sanofi, AbbVie, Pfizer, Leo Pharma, Novartis among others.
Canada Atherosclerosis Therapeutics Market Analysis
Canada Atherosclerosis Therapeutics Market was valued at $224 Mn in 2022 and is estimated to reach $349 Mn in 2030, exhibiting a CAGR of 5.7% during the forecast period. The increasing prevalence of cardiovascular diseases, driven by the global aging population and rising occurrences of sedentary behaviour and unhealthy diets, is expected to fuel the demand for atherosclerosis therapeutics. The leading pharmaceutical companies currently operating in the industry are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Johnson & Johnson, Eli Lilly, AbbVie, Roche and Teva Pharmaceutical Industries
Canada HIV Drugs Market Analysis
Canada HIV Drugs Market is at around $2.54 Bn in 2023 and is projected to reach $3.25 Bn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The market is growing due to the prevalence of HIV/ AIDS, government initiatives and funding, and advancements in drug therapies. The market is dominated by key players like ViiV Healthcare, Gilead Sciences, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffman-La Roche Ltd., Cipla, Teva Pharmaceutical Industries Ltd., and Johnson & Johnson.